Literature DB >> 19944924

Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites.

Sharon K Greene1, Ping Shi, M Maya Dutta-Linn, Jo Ann Shoup, Virginia L Hinrichsen, Paula Ray, James D Nordin, Leslie Kuckler, Eric S Weintraub, W Katherine Yih.   

Abstract

BACKGROUND: Studies of influenza vaccination using electronic medical records rely on accurate classification of vaccination status. Vaccinations not entered into electronic records would be unavailable for study.
PURPOSE: This study evaluated the sensitivity and negative predictive value (NPV) of electronic records for influenza vaccination and factors associated with failure to capture vaccinations.
METHODS: In four diverse medical care organizations in the Vaccine Safety Datalink, those aged 50-79 years with no influenza vaccination record during the 2007-2008 season were surveyed by telephone, and electronic records were analyzed in 2008. The sensitivity and NPV of electronic records were estimated, using survey responses as the gold standard. Logistic regression models determined associations between 1-NPV and demographic factors, risk of influenza complications, and healthcare utilization levels.
RESULTS: Data were obtained for 933 survey participants and 1,085,916 medical care organization members. Sites varied significantly in the sensitivity (51%, 68%, 79%, 89%) and NPV (46%, 62%, 66%, 87%) of electronic records. In multivariate analysis, the rate of failure to capture vaccinations was significantly higher for those aged 65-79 years than for those aged 50-64 years at three sites. Of vaccinations not captured by electronic records, 58% were reportedly administered in nontraditional settings, usually workplaces; the rest were given within the sites.
CONCLUSIONS: Influenza vaccination studies relying on electronic records may misclassify substantial proportions of vaccinated individuals as unvaccinated, producing biased estimates of vaccine effectiveness. Sites with limited sensitivity to capture vaccinations administered within their organization should seek possible remedies. More complete capture of vaccinations administered to older patients and in nontraditional settings would further reduce misclassification.

Entities:  

Mesh:

Year:  2009        PMID: 19944924     DOI: 10.1016/j.amepre.2009.08.022

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  16 in total

1.  Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Authors:  Sharon K Greene; Melisa Rett; Eric S Weintraub; Lingling Li; Ruihua Yin; Anthony A Amato; Doreen T Ho; Sarah I Sheikh; Bruce H Fireman; Matthew F Daley; Edward A Belongia; Steven J Jacobsen; Roger Baxter; Tracy A Lieu; Martin Kulldorff; Claudia Vellozzi; Grace M Lee
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

2.  Effects of automated immunization registry reporting via an electronic health record deployed in community practice settings.

Authors:  J Merrill; A Phillips; J Keeling; R Kaushal; Y Senathirajah
Journal:  Appl Clin Inform       Date:  2013-06-12       Impact factor: 2.342

3.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

4.  Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

Authors:  S J Rolnick; E D Parker; J D Nordin; B D Hedblom; F Wei; T Kerby; J M Jackson; A L Crain; G Euler
Journal:  Vaccine       Date:  2013-06-24       Impact factor: 3.641

5.  The use of health information technology to improve care and outcomes for older adults.

Authors:  Kathryn H Bowles; Patricia Dykes; George Demiris
Journal:  Res Gerontol Nurs       Date:  2015 Jan-Feb       Impact factor: 1.571

6.  Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults.

Authors:  H Keipp Talbot; Marie R Griffin; Qingxia Chen; Yuwei Zhu; John V Williams; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

7.  Live attenuated influenza vaccine use and safety in children and adults with asthma.

Authors:  Jonathan Duffy; Melissa Lewis; Theresa Harrington; Roger Baxter; Edward A Belongia; Lisa A Jackson; Steven J Jacobsen; Grace M Lee; Allison L Naleway; James Nordin; Matthew F Daley
Journal:  Ann Allergy Asthma Immunol       Date:  2017-04       Impact factor: 6.347

8.  Agreement among sources of adult influenza vaccination in the age of immunization information systems.

Authors:  Mary Patricia Nowalk; Helen Eleni Aslanidou D'Agostino; Richard K Zimmerman; Sean G Saul; Michael Susick; Jonathan M Raviotta; Theresa M Sax; G K Balasubramani
Journal:  Vaccine       Date:  2021-10-27       Impact factor: 3.641

9.  Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.

Authors:  Mary Catherine Cambou; Timothy P Copeland; Karin Nielsen-Saines; James Macinko
Journal:  Vaccine       Date:  2021-03-18       Impact factor: 3.641

10.  Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Authors:  Sharon K Greene; Melisa D Rett; Claudia Vellozzi; Lingling Li; Martin Kulldorff; S Michael Marcy; Matthew F Daley; Edward A Belongia; Roger Baxter; Bruce H Fireman; Michael L Jackson; Saad B Omer; James D Nordin; Robert Jin; Eric S Weintraub; Vinutha Vijayadeva; Grace M Lee
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.